Literature DB >> 18759153

In-hospital mortality in non-variceal upper gastrointestinal bleeding Forrest 1 patients.

Francesco Manguso1, Elisabetta Riccio, Raffaele Bennato, Salvatore Picascia, Rossana Martino, Germana De Nucci, Roberta Fiorito, Antonio Balzano.   

Abstract

OBJECTIVE: Non-variceal upper gastrointestinal bleeding (NVUGIB) is recognized world-wide as a common cause of emergency hospitalization, and it often represents a life-threatening event. The purpose of this prospective study was to assess in-hospital mortality in NVUGIB Forrest 1 patients admitted to the emergency unit owing to active bleeding.
MATERIAL AND METHODS: We enrolled all patients consecutively admitted to the emergency unit for NVUGIB, acutely bleeding at endoscopy (spurting or oozing). Demographic characteristics, clinical and biochemical parameters, endoscopic findings and treatments were evaluated.
RESULTS: Of a total of 142 patients (98 M (69%), mean age+/-SD=66+/-14 years), spurting (16 (11.3%)) and oozing (126 (88.7%)) were identified. All patients received endoscopic treatment within 6 h of admission and were managed according to the guidelines. Seventeen (12%) patients suffered rebleeding, 4 patients (2.8%) required surgery to stop the bleeding, and 8 (5.6%) died during hospitalization (4 within 5 days and the remainder within 24 days of admission) - 3 as a consequence of bleeding (2.1%) and 5 of non-surgical complications (3.5%). Cox regression analysis showed that the lesions in more than one segment of the esophagogastroduodenal tract (p=0.008, hazard ratio (95% CI)=7.623 (1.680-34.600)) and the number of blood units transfused during the first 48 h of hospitalization (p=0.038, 2.075 (1.041-4.135)) were predictive of in-hospital death.
CONCLUSIONS: In Forrest 1 patients given rapid endoscopic treatment, in-hospital mortality seems to be related to the contemporaneous presence of bleeding and non-bleeding lesions in more than one segment of the esophagogastroduodenal tract and the number of blood units transfused during the first 48 h of hospitalization.

Entities:  

Mesh:

Year:  2008        PMID: 18759153     DOI: 10.1080/00365520802307989

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Greek results of the "ENERGIB" European study on non-variceal upper gastrointestinal bleeding.

Authors:  George Papatheodoridis; Evangelos Akriviadis; Nikolaos Evgenidis; Anargyros Kapetanakis; Demetrios Karamanolis; Jannis Kountouras; Gerassimos Mantzaris; Spyros Potamianos; Konstantinos Triantafyllou; Charalambos Tzathas
Journal:  Ann Gastroenterol       Date:  2012

2.  Resuming aspirin in patients with non-variceal upper gastrointestinal bleeding: a systematic review and meta-analysis.

Authors:  Jana G Hashash; Roni Aoun; Nadim El-Majzoub; Assem Khamis; Don Rockey; Elie A Akl; Kassem Barada
Journal:  Ann Gastroenterol       Date:  2021-03-23

3.  Predictive factors of mortality within 30 days in patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Yoo Jin Lee; Bo Ram Min; Eun Soo Kim; Kyung Sik Park; Kwang Bum Cho; Byoung Kuk Jang; Woo Jin Chung; Jae Seok Hwang; Seong Woo Jeon
Journal:  Korean J Intern Med       Date:  2015-12-28       Impact factor: 2.884

4.  Thromboelastography-derived parameters for the prediction of acute thromboembolism following non-steroidal anti-inflammatory drug-induced gastrointestinal bleeding: A retrospective study.

Authors:  Tian-Yu Chi; Ying Liu; Hong-Ming Zhu; Mei Zhang
Journal:  Exp Ther Med       Date:  2018-07-18       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.